Cabot Corporation
CBTBasic MaterialsNASDAQSpecialty Chemicals · Last scanned May 29, 2026
Scan Results
Daily timeframeCabot Corporation operates as a specialty chemicals and performance materials company. Valued at $4.53B, CBT is a mid-cap name in its sector. It operates through two segments, Reinforcement Materials and Performance Chemicals.
Market Cap
$4.53B
Beta
0.78
P/E (TTM)
16.55
P/E (Fwd)
12.66
EPS (TTM)
$5.30
EPS (Fwd)
$6.93
ROE
20.0%
ROA
9.5%
Cash
$252.0M
Total Debt
$1.31B
Free CF
$374.1M
52W Change
17.4%
Annual Financials
Cash vs Debt
On the balance sheet, CBT has $252.0M in cash with $1.31B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $374.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 20.0%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 9.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has pulled back from $4.32B (2022) to $3.71B (2025), a 14% decline worth watching.
Cabot Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CBT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.